Merck ties up with Thermo Fisher to make its COVID-19 pill in Canada

Signage is seen at the Merck & Co. headquarters in Kenilworth, New Jersey, U.S., November 13, 2021. REUTERS/Andrew KellyDec 6 (Reuters) – Drugmaker Merck & Co (MRK.N) on Monday announced a deal with medical device maker Thermo Fisher Scientific (TMO.N) to manufacture its experimental COVID-19 pill at a site in Ontario.Thermo Fisher’s manufacturing site in Whitby will manufacture molnupiravir for distribution in Canada and the United Kingdom as well as markets in the European Union, Asia Pacific and Latin America.Register now for FREE unlimited access to reuters.comRegisterReporting by Manojna Maddipatla in Bengaluru; Editing by Amy Caren DanielOur Standards: The Thomson Reuters Trust Principles.

Source link

Leave a Comment

%d bloggers like this: